John D. Schuetz

Active 1984–2025

99
Papers
21,493
Citations
81
h-index
95
i10-index

Citations

Citations per year for John D. Schuetz1983: 1 citations1985: 1 citations1986: 2 citations1988: 1 citations1989: 4 citations1990: 5 citations1991: 10 citations1992: 18 citations1993: 14 citations1994: 14 citations1995: 53 citations1996: 65 citations1997: 84 citations1998: 143 citations1999: 132 citations2000: 162 citations2001: 173 citations2002: 296 citations2003: 402 citations2004: 398 citations2005: 478 citations2006: 460 citations2007: 381 citations2008: 419 citations2009: 304 citations2010: 293 citations2011: 231 citations2012: 229 citations2013: 197 citations2014: 163 citations2015: 169 citations2016: 109 citations2017: 138 citations2018: 109 citations2019: 347 citations2020: 344 citations2021: 299 citations2022: 257 citations2023: 171 citations2024: 272 citations2025: 109 citations2026: 2 citations1984: no citations, so this year is not shown1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,509 citing papers, 33.2% of this breakdownChina: 538 citing papers, 7.1% of this breakdownGermany: 456 citing papers, 6% of this breakdownUnited Kingdom: 435 citing papers, 5.8% of this breakdownJapan: 414 citing papers, 5.5% of this breakdownNetherlands: 312 citing papers, 4.1% of this breakdownCanada: 272 citing papers, 3.6% of this breakdownFrance: 243 citing papers, 3.2% of this breakdownItaly: 207 citing papers, 2.7% of this breakdownAustralia: 200 citing papers, 2.7% of this breakdownSwitzerland: 162 citing papers, 2.2% of this breakdownSweden: 151 citing papers, 2% of this breakdown
0%33.2%Other 21.9%

Fields

  • Medicine60.5%
  • Biochemistry, Genetics and Molecular Biology19.3%
  • Pharmacology, Toxicology and Pharmaceutics14.2%
  • Environmental Science1%
  • Immunology and Microbiology0.9%
  • Neuroscience0.9%
  • Other3.2%

Topics

  • Drug Transport and Resistance Mechanisms13%
  • Pharmacogenetics and Drug Metabolism7.4%
  • Pharmacological Effects and Toxicity Studies4.6%
  • HIV/AIDS drug development and treatment2.1%
  • Cancer Cells and Metastasis2%
  • Drug-Induced Hepatotoxicity and Protection1.6%
  • Other69.3%

Coauthors

All papers

Open in search
  1. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

    Authors: , , , , , , , , , , , , , , , , , , - Nature Genetics 2001 cited by 2,161

  2. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

    Authors: , , , , , , , , , , - Nature Medicine 2001 cited by 2,276

  3. Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction

    Authors: , , , , , , , , - Genes & Development 2013 cited by 272

  4. The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 93

  5. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration

    Authors: , , , , , , , , , , , , - Nature Cell Biology 2012 cited by 400

  6. Identification of a mammalian mitochondrial porphyrin transporter

    Authors: , , , , , , , , , - Nature 2006 cited by 355

  7. AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aditya Kumar, Minko Gehev, Pierre-Yves Aquilanti, Henry A. Gabb, Amr Alhossary, Gerhard Wagner, Alán Aspuru‐Guzik, Yurii S. Moroz, Gerhard Wagner, Konstantin Fackeldey, Yurii S. Moroz, Haribabu Arthanari, Konstantin Fackeldey, John D. Schuetz, Andrea Mattevi, Haribabu Arthanari, Christoph Gorgulla - 2023 cited by 26

  8. The Arachidonic Acid Metabolome Serves as a Conserved Regulator of Cholesterol Metabolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keiji Kuba, Yumiko Imai, Makoto Arita, John D. Schuetz, Peter P. Pramstaller, Uwe J.F. Tietge, Michael Trauner, Giuseppe Danilo Norata, Thierry Claudel, Andrew A. Hicks, Günter Weiß, Ivan Tancevski - Cell Metabolism 2014 cited by 117

  9. Linker Domains: Why ABC Transporters ‘Live in Fragments no Longer’

    Authors: , , - Trends in Biochemical Sciences 2019 cited by 42

  10. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice

    Authors: , , , , , , , , , , , , - Gastroenterology 2003 cited by 261

  11. Mutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1

    Authors: , , , , , , , , - Journal of Biological Chemistry 2001 cited by 244

  12. Obstacles to Brain Tumor Therapy: Key ABC Transporters

    Authors: , , - International Journal of Molecular Sciences 2017 cited by 104

  13. The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme

    Authors: , , , , , , , , - Journal of Biological Chemistry 2004 cited by 653

  14. Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450

    Authors: , , , , , , , , , , , , , , - Journal of Biological Chemistry 2001 cited by 391

  15. Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in Vitro

    Authors: , , , , , , - Cancer Research 2004 cited by 322

  16. The role of transporters in cellular heme and porphyrin homeostasis

    Authors: , , - Pharmacology & Therapeutics 2007 cited by 267

  17. Prostaglandin signalling regulates ciliogenesis by modulating intraflagellar transport

    Authors: , , , , , , , , , , , , , , , , , - Nature Cell Biology 2014 cited by 105

  18. Abcb11 Deficiency Induces Cholestasis Coupled to Impaired β-Fatty Acid Oxidation in Mice

    Authors: , , , , , , , , , , , - Journal of Biological Chemistry 2012 cited by 86

  19. Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3

    Authors: , , , , , , , , , - Molecular Pharmacology 2001 cited by 324

  20. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)

    Authors: , , , , , , - Biochemical Journal 2003 cited by 311

  21. ABC transporters and their role in nucleoside and nucleotide drug resistance

    Authors: , - Biochemical Pharmacology 2012 cited by 123

  22. Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters

    Authors: , , , , , , , , , , - PLoS ONE 2021 cited by 20

  23. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs

    Authors: , , , , , , , - Nature Medicine 1999 cited by 579

  24. High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter

    Authors: , , , , , , , , , - Molecular Pharmacology 2004 cited by 340